Anogenital pruritus, unspecified
ICD-10 L29.3 is a billable code used to indicate a diagnosis of anogenital pruritus, unspecified.
Anogenital pruritus, unspecified, refers to itching in the anal and genital areas without a specified underlying cause. This condition can affect individuals of all ages and genders, presenting as a persistent or intermittent sensation of itchiness that may lead to scratching, discomfort, and secondary skin changes such as erythema, excoriation, or infection. The anatomy involved includes the skin and mucous membranes of the perianal and genital regions, which are sensitive and can react to various irritants, allergens, or infections. Disease progression may vary; chronic pruritus can lead to significant distress and impact quality of life. Diagnostic considerations include a thorough history and physical examination to rule out common causes such as infections (e.g., candidiasis, bacterial infections), dermatological conditions (e.g., eczema, psoriasis), systemic diseases (e.g., diabetes, liver disease), and irritants (e.g., soaps, hygiene products). In some cases, referral to a dermatologist may be necessary for further evaluation and management.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
L29.3 covers unspecified anogenital pruritus, which may arise from various conditions including infections, inflammatory skin diseases, or irritant dermatitis. It is important to document any suspected underlying causes for accurate coding.
L29.3 should be used when the pruritus is localized to the anogenital area and no specific underlying condition has been identified. If a specific cause is determined, a more specific code should be utilized.
Documentation should include a detailed patient history, description of symptoms, physical examination findings, and any treatments attempted. This information is crucial for justifying the use of L29.3 in billing and coding.
